ESR1 and breast cancer: Although one study found that current soy isoflavone supplements were associated with an increased risk of ER‐breast cancer and a decreased risk of estrogen receptor positive (ER+) breast cancer, two Western studies that evaluated soy or soy isoflavone supplements did not find any association between soy or soy isoflavone supplements and overall breast cancer risk.